Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-04-19
2011-04-19
Reddig, Peter J (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S300000, C530S325000, C530S326000, C530S350000
Reexamination Certificate
active
07927816
ABSTRACT:
The invention provides a method of identifying an effective compound that modulates the binding of Humanin to Bax or Bid. The invention also provides a method of identifying an effective compound that modulates an activity of Bax or Bid. In addition, the invention provides a method of identifying a Humanin-like compound that binds to Bax or Bid or modulates an activity of Bax or Bid, or inhibits the apoptotic activity of Bax or Bid. The invention further provides an isolated polypeptide containing a mitochondrial-derived form of Humanin (SEQ ID NO:3) or a functional fragment thereof where the fragment contains the methionine at position 16 of SEQ ID NO:3.
REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 5264563 (1993-11-01), Huse
patent: 5501979 (1996-03-01), Geller et al.
patent: 5506138 (1996-04-01), Gelboin et al.
patent: 5561063 (1996-10-01), Hock et al.
patent: 5604090 (1997-02-01), Alexander et al.
patent: 5674703 (1997-10-01), Woo et al.
patent: 5693508 (1997-12-01), Chang
patent: 5700470 (1997-12-01), Saito et al.
patent: 5719054 (1998-02-01), Boursnell et al.
patent: 5731172 (1998-03-01), Saito et al.
patent: 5739018 (1998-04-01), Miyanohara et al.
patent: 6130317 (2000-10-01), Reed et al.
patent: 6165732 (2000-12-01), Korsmeyer et al.
patent: 6245885 (2001-06-01), Shore et al.
patent: 7314864 (2008-01-01), Nishimoto
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 2003/0176671 (2003-09-01), Reed et al.
patent: 1 221 480 (2002-07-01), None
patent: WO 01/21787 (2001-03-01), None
Zhu et al. (J. Biol. Chem. 2005 280: 15,815-15,824).
Day et al. (Mol. Endo. 2005 19:1675-1686).
Bowie et al (Science, 1990, 257:1306-1310).
Skolnick et al. (TIBTECH 18:34-39, 2000).
Ibragimova and Eade (Biophysical Journal, Oct. 1999, vol. 77, pp. 2191-2198).
Burgess et al (J. of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Alouani, “Scintillation proximity binding assay,”Methods Mol. Biol. 138:135-141 (2000).
Altschul et al., “Basic local alignment search tool,”J. Mol. Biol. 215:403-410 (1990).
Bauminger and Wilchek, “The use of carbodiimides in the preparation of immunizing conjugates,”Methods Enzymol. 70:151-159 (1980).
Bork, “Powers and pitfalls in sequence analysis: the 70% hurdle,”Genome Res. 10(4):398-400 (2000).
Burgess et al., “Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue,”J. Cell Biol. 111(5 Pt 1):2129-2138 (1990).
Chen and Shapiro, “Affinity NMR,”Anal. Chem. 71:669A-675A (1999).
Cherfils et al., “Protein-protein recognition analyzed by docking simulation,”Proteins11:271-280 (1991).
Chou et al., “Solution structure of BID, an intracellular amplifier of apoptotic signaling,”Cell96:615-624 (1999).
Degterev et al., “Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL,”Nat. Cell. Biol. 3:173-182 (2001).
Deutscher, “Setting up a laboratory,”Methods Enzymol. 182:19-23 (1990).
Eckert et al., “Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket,”Cell99:103-115 (1999).
Egleton and Davis, “Bioavailability and transport of peptides and peptide drugs into the brain,”Peptides18:1431-1439 (1997).
Eichler et al., “Peptide, peptidomimetic, and organic synthetic combinatorial libraries,”Med. Res. Rev. 15:481-496 (1995).
Elbashir et al., “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells,”Nature411:494-498 (2001).
Fancy, “Elucidation of protein-protein interactions using chemical cross-linking or label transfer techniques,”Curr Opin Chem Biol. 4:28-33 (2000).
Fields and Song, “A novel genetic system to detect protein-protein interactions,”Nature340:245-246 (1989).
Francis et al., “Combinatorial libraries of transition-metal complexes, catalysts and materials,”Curr. Opin. Chem. Biol. 2:422-428 (1998).
Galfre and Milstein, “Preparation of monoclonal antibodies: strategies and procedures,”Methods Enzymol. 73:3-46 (1981).
Gallop et al., “Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries,”J. Med. Chem. 37:1233-1251 (1994).
Gervais et al., “Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation,”Cell97:395-406 (1999).
Gordon et al., “Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions,”J. Med. Chem. 37:1385-1401 (1994).
Gossen and Bujard, “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters,”Proc. Natl. Acad. Sci. U.S.A. 89:5547-5551 (1992).
Gossen et al., “Transcriptional activation by tetracyclines in mammalian cells,”Science268:1766-1769 (1995).
Hajduk et al., “High-throughput nuclear magnetic resonance-based screening,”J. Med. Chem. 42:2315-2317 (1999).
Hashimoto et al., “A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ,”Proc. Natl. Acad. Sci. U. S. A. 98(11):6336-6341 (2001).
Hashimoto et al., “Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein,”Biochem. Biophys. Res. Commun. 283:460-468 (2001).
Hengartner, “The biochemistry of apoptosis,”Nature407:770-776 (2000).
Horwell, “The ‘peptoid’ approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides,”Trends Biotechnol. 13:132-134 (1995).
Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda,”Science246:1275-1281 (1989).
Ikeda et al., “Gd-enhanced dynamic magnetic resonance imaging of breast masses,”Top Magn. Reson. Imaging10:143-151 (1999).
Jayasena, “Aptamers: An emerging class of molecules that rival antibodies in diagnostics,”Clin. Chem. 45:1628-1650 (1999).
Jin and Reed, “Yeast and apoptosis,”Nat. Rev. Mol. Cell. Biol. 3:453-459 (2002).
Jürgensmeier et al., “Bax directly induces release of cytochromecfrom isolated mitochondria,”Proc. Natl. Acad. Sci. U.S.A. 95:4997-5002 (1998).
Kermer et al., “Bag1 is a regulator and marker of neuronal differentiation,”Cell Death Differ. 9:405-413 (2002).
Lau et al., “Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents,”Bioorg. Med. Chem. 3:1299-1304 (1995).
Lazar et al., “Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities,”Mol. Cell Biol. 8(3):1247-1252 (1988).
Leblanc et al., “Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease,”J. Biol. Chem. 274:23426-23436 (1999).
Lee et al., “Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids,”Nature294:228-232 (1981).
Lengauer and Rarey, “Computational methods for biomolecular docking,”Curr. Opin. Struct. Biol. 6:402-406 (1996).
Leonard et al., “Bid regulation of neuronal apoptosis,”Brain Res. Dev. Brain Res. 128:187-190 (2001).
Lipton and Rosenberg, “Excitatory amino acids as a final common pathway for neurologic disorders,”N. Engl. J. Med. 330:613-622 (1994).
Loo et al., “Application of mass spectrometry for target identification and characterization,&#x
Guo Bin
Reed John C.
Day Jones
Reddig Peter J
Sanford-Burnham Medical Research Institute
LandOfFree
Methods for identifying modulators of apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying modulators of apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying modulators of apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2707239